The activation of PPARγ ligands is well known to cause the death of cancer cells via multiple channels such as activating the anti-tumor immune system, differentiating cancer cells, arresting cell cycle, promoting apoptosis and increasing radioiodine uptake (1–12). This evidence concerns the gene PPARG and cancer.